Boardroom Alpha
10-K primary document
EBS · Annual Report (Form 10-K) · Filed February 27, 2026

Emergent Biosolutions Inc10-K exhibit

subsidiariesofthecompany1.htm
Document

List of Subsidiaries
(as of December 31, 2025)


Name of Subsidiary
Jurisdiction of Incorporation or Organization
Domestic
400 Professional LLC
Delaware
Cangene bioPharma LLC
Maryland
Emergent Commercial Operations Frederick Inc.
Maryland
Emergent Biodefense Operations Lansing LLC
Delaware
Emergent Devices Inc.
Delaware
Emergent Europe Inc.
Delaware
Emergent International Inc.
Delaware
Emergent Manufacturing Operations Baltimore LLC
Delaware
Emergent Product Development Gaithersburg Inc.
Delaware
Emergent Travel Health Inc.
Delaware
International
Emergent Acquisition Unlimited Company
Ireland
Emergent BioSolutions Canada Inc.
Ontario
Emergent BioSolutions Ireland Limited
Ireland
*Emergent Netherlands B.V.
Netherlands
Emergent Operations Ireland Limited
Ireland
Emergent Sales and Marketing Australia Pty Ltd.
Australia
Emergent Sales and Marketing Germany GmbH
Germany
Emergent Sales and Marketing Singapore Pte. Ltd.
Singapore
Emergent BioSolutions UK Ltd.
England and Wales

*The Company chose not to proceed with the dissolution of this entity indicated in FY25.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer